# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Leonardo da Vinci (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE001-SYN
- Date: 2026-08-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Carrow-Asante, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review with nerve studies and ultrasound; hand surgery consultation today. **S**

## History of present illness

Mr. da Vinci returns two weeks after his first visit, six weeks after he slipped on the stone stairs and landed on his bent right elbow. The numbness of the little finger and the inner half of the ring finger and the weakness of the right hand are unchanged; the ring and little fingers still curl when he opens his hand, and he cannot hold the palette or a fine brush. Elbow pain has eased with acetaminophen. He has used a towel around the elbow at night and a gel pad at the drawing table. He has had no new symptoms in the face, speech, vision, legs, or left hand. His home blood pressure readings over a week averaged 127/77 mmHg. He had nerve conduction studies, EMG, and an ultrasound this morning and saw Dr. Lindqvist-Obi of hand surgery afterwards. He draws and writes with his left hand as before. **S**

| Element | Detail |
|---|---|
| Onset | Six weeks ago, within two days of a fall onto the bent right elbow |
| Symptoms | Numb little finger and inner ring finger; weak grip and pinch; curling of the ring and little fingers |
| Function | Cannot hold the palette or a fine brush; drawing and writing with the left hand unaffected |
| Home blood pressure | Average 127/77 mmHg over seven days |
| Pertinent negatives | No face, speech, vision, leg, or left-hand symptoms; no neck pain |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Right ulnar numbness and hand weakness; no headache, speech, vision, or face symptoms; no leg weakness |
| Musculoskeletal | Positive | Ache at the inner right elbow, easing; no neck pain |
| Cardiovascular | Negative | No palpitations, chest pain, or fainting |

3 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours as needed for elbow pain, no more than 3 g a day **S**
- Atorvastatin 20 mg oral tablet, one tablet by mouth each evening **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 74 kg; BMI 24.2 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| Neurological, general | Alert; fluent speech with normal naming; no facial weakness; no pronator drift; NIH Stroke Scale 0; strength, reflexes, and sensation normal in the left arm and both legs; Hoffmann sign absent; plantar responses flexor |
| Right arm | Sensory loss over the little finger, the ulnar half of the ring finger, and the dorsal ulnar hand (two-point discrimination 10 mm at the little finger against 4 mm on the left); first dorsal interosseous 3/5, abductor digiti minimi 3/5, deep flexor of the little finger 4/5, flexor carpi ulnaris 5/5; thumb abduction, wrist and finger extension 5/5; Froment and Wartenberg signs positive; mild clawing of the ring and little fingers; early wasting of the first web space |
| Right elbow | Tinel sign over the cubital tunnel positive; elbow flexion test positive at 30 seconds; nerve does not sublux; full range of motion; bruise resolved |
| Neck | Full movement; Spurling test negative |
| Cardiovascular | Regular pulse 70; no carotid bruit; blood pressure 128/78 mmHg |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ulnar neuropathy at the right elbow (cubital tunnel), post-traumatic** (G56.21). Sensory loss in the ulnar fingers and the dorsal ulnar hand, with weakness of the intrinsic muscles and the deep flexor of the little finger, localizes to the ulnar nerve at or above the elbow, not at the wrist. Nerve conduction studies show focal slowing across the elbow (36 m/s against 57 m/s in the forearm) and a 38 percent fall in amplitude, meeting AANEM criteria for ulnar neuropathy at the elbow; EMG shows active denervation in ulnar hand muscles with normal median, radial, and C8 paraspinal muscles, excluding C8 radiculopathy and lower trunk plexopathy. Ultrasound shows a swollen nerve at the medial epicondyle with no ganglion or subluxation. The elbow X-ray showed no fracture. A stroke is excluded: the weakness follows one peripheral nerve, the rest of the neurological examination is normal, and the MRI of the brain showed no infarct. Severity is moderate to severe, with some axonal loss. **S**
   - Night elbow splint and daytime anti-claw splint, fitted in the clinic today.
   - Hand therapy twice a week: strength, dexterity, and adapted tools for painting.
   - No corticosteroid injection.
   - Conservative treatment for about three months from the injury, with grip, pinch, and two-point discrimination at each review; surgery to be discussed if strength does not improve, as Dr. Lindqvist-Obi advises.
2. **Right hand weakness, numbness, and curling of the fingers** (R29.818). Explained by ulnar neuropathy at the elbow; superseded by that diagnosis. **S**
   - Managed under the ulnar neuropathy.
3. **Primary hypercholesterolemia** (E78.00). LDL 146 mg/dL, HDL 49 mg/dL, lipoprotein(a) 42 nmol/L; HbA1c 5.5 percent; home blood pressure 127/77 mmHg; ECG in sinus rhythm; never smoker. The Pooled Cohort Equations give a 10-year ASCVD risk of 13.5 percent, which meets the USPSTF threshold for a statin; the newer PREVENT equations give 6.9 percent, in the borderline range. After discussing both estimates and the option of a coronary calcium scan, he chose to start a statin. **S**
   - Atorvastatin 20 mg each evening, starting today.
   - Lipid panel in about eight weeks.
   - Report muscle aches.
4. **History of falling** (Z91.81). A slip on poorly lit stairs, with no dizziness, palpitations, or loss of consciousness before it; ECG normal. **S**
   - Handrail for the open side of the staircase and night lighting.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Ulnar motor and sensory examination: strength of the first dorsal interosseous, abductor digiti minimi, and deep flexor of the little finger (MRC grade), two-point discrimination of the little finger, Froment and Wartenberg signs, clawing, and wasting | Every visit during treatment | Completed today | Two-point discrimination 10 mm at the little finger; first dorsal interosseous 3/5, abductor digiti minimi 3/5, deep flexor of the little finger 4/5; Froment and Wartenberg positive; mild clawing and early first web wasting |
| Examination | Grip and key-pinch dynamometry, both hands | Every visit during treatment | Completed today | Grip 20 kg right, 38 kg left; key pinch 3.0 kg right, 7.5 kg left |
| Survey | Patient-reported hand function (QuickDASH) | Before treatment, then at each review | Deferred | Missed at intake: the score was not taken at the first visit. Outcome: first score taken today, before the splints were fitted, 52 of 100, so a pre-treatment baseline still exists and no harm resulted. Corrective action: the QuickDASH is now part of the clinic's intake template for hand complaints |
| Imaging | Nerve conduction studies and needle EMG | Once to confirm the site and severity, at least three weeks after the injury | Completed today | Focal slowing and partial conduction block across the elbow; active denervation in ulnar hand muscles; no radiculopathy or plexopathy |
| Imaging | Ultrasound of the ulnar nerve at the elbow | Once at diagnosis | Completed today | Nerve swollen at the medial epicondyle (14 mm2); no subluxation or mass |
| Imaging | X-ray of the elbow after the fall | Once, after trauma | Up to date | No fracture at the first visit |
| Imaging | MRI of the brain to exclude stroke | Once, at presentation | Up to date | No infarct at the first visit |
| Self-management | Splint use and avoiding pressure on and prolonged bending of the elbow | Every visit during treatment | Completed today | Splints fitted today; elbow pad in use; no leaning on the elbow |
| Referral | Hand surgery consultation | At diagnosis of ulnar neuropathy with weakness | Completed today | Seen today; conservative trial agreed, with a surgical review at about three months |
| Referral | Hand therapy | Twice a week from diagnosis | Referred | Requested today |
| Medication safety | Corticosteroid injection at the cubital tunnel | Not part of treatment | Not indicated | No benefit over placebo at three months in the Cochrane review |
| Laboratory | Lipid panel, HbA1c, ALT, and lipoprotein(a) before a statin | Baseline before starting | Completed today | First-visit results reviewed today: LDL 146 mg/dL, HbA1c 5.5 percent, ALT 21 U/L, Lp(a) 42 nmol/L |
| Laboratory | Creatine kinase before a statin | Baseline only with a high risk of muscle symptoms | Not indicated | No risk factors for statin muscle symptoms |
| Laboratory | Lipid panel after starting a statin | 4 to 12 weeks after starting or changing | Due | Atorvastatin starts today |
| Survey | 10-year ASCVD risk estimate | Every 4 to 6 years, and when a statin is considered | Completed today | Pooled Cohort Equations 13.5 percent; PREVENT 6.9 percent |
| Examination | Blood pressure, weight, and smoking status | Every visit | Completed today | 128/78 mmHg; home average 127/77 mmHg; 74.0 kg; never smoker |
| Examination | Atrial fibrillation check (pulse and ECG) | At presentation with focal weakness | Up to date | Sinus rhythm on the first-visit ECG; pulse regular today |

## Goal progress

- Stroke excluded and the lesion localized by the second visit. Outcome by 2026-08-17: Normal neurological examination apart from the right ulnar territory; MRI brain normal; nerve conduction studies, EMG, and ultrasound confirm ulnar neuropathy at the elbow. **S**
- Keep working: drawing, writing, and teaching with the left hand, and painting with adapted tools and help. In progress; target 2027-02-01. **S**
- Recovery of ulnar sensation and intrinsic strength, judged at about three months from the injury. In progress; target 2027-02-01. **S**
- LDL down by 30 to 49 percent on a moderate-intensity statin. In progress; target 2026-10-20. **S**
- No further falls. In progress; target 2027-08-01. **S**

## Medication changes

- Started: Atorvastatin 20 mg oral tablet, one tablet by mouth each evening **S**

## Guideline basis

- Cubital Tunnel Syndrome (Ulnar Nerve Entrapment at the Elbow), OrthoInfo (2026), American Academy of Orthopaedic Surgeons
- Treatment for ulnar neuropathy at the elbow (Caliandro P, et al.) (2025), Cochrane Database of Systematic Reviews
- Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow: summary statement (American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation) (1999), Muscle & Nerve
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association (2021), American Heart Association / American Stroke Association (Stroke)
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018), American Heart Association / American College of Cardiology (Circulation)
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, hyperlipidemia monograph (2026), Aether Forge

## Follow-up

- Review in four weeks with grip, pinch, and sensation; lipid panel in about eight weeks. **S**
- Next scheduled visit 2026-09-14: four-week review of the ulnar neuropathy on splinting and hand therapy. **S**
